SWK Holdings focuses on pharmaceutical development, manufacturing and intellectual property licensing business. Co.'s operations comprise two reportable segments: Finance Receivables, which provides customized financing solutions to a range of life science companies, institutions and inventors, and focuses on commercial-stage products and related intellectual property through royalty purchases and financings, as well as through commercialized products; and Pharmaceutical Development, in which through its subsidiary, Enteris BioPharma, Inc., provides formulation solutions built around its proprietary oral drug delivery technologies, the Peptelligence® platform. We show 19 historical shares outstanding datapoints in our SWKH shares outstanding history coverage, used to compute SWKH market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing SWKH market cap history over the course of time is important for investors
interested in comparing SWKH's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of SWKH versus a peer is one thing; comparing
SWKH market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like SWKH can fluctuate over the course of history.
With this page we aim to empower investors researching SWKH by allowing them to research the SWKH market cap history. |
Free SWKH Email Alerts:
Video: The Importance of Market Cap
